Formosa Laboratories Inc (4746.TW)

4746.TW

About

Formosa Laboratories, Inc. is principally engaged in the development, production and distribution of ultraviolet (UV)-proof active ingredients, vitamin D derivatives and anti-inflammatory analgesic drugs. The Company primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflam... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	1.42
Market Cap (Mil.):	NT$3,205.35
Shares Outstanding (Mil.):	67.27
Dividend:	--
Yield (%):	--

Financials

	4746.TW	Industry	Sector
P/E (TTM):	--	19.58	20.41
EPS (TTM):	-2.73	--	--
ROI:	-8.26	5.07	16.61
ROE:	-10.77	7.26	18.86

Latest News about 4746.TW

» More 4746.TW News

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - FORMOSA LABORATORIES, INC (4746-TW) Provider: Thomson Reuters Stock Report	$25.00 Buy
Formosa Laboratories Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Wright Investors Service Comprehensive Report for Formosa Laboratories, Inc Provider: Wright Reports	$460.00 Buy
Formosa Laboratories, Inc. (4746) - Financial Analysis Review Provider: GlobalData	$125.00 Buy
Formosa Laboratories, Inc. (4746) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Provider: GlobalData	$250.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.